| |
|
|
|
Fulgent Genetics Inc
|
|
3.94 +0.10 (+2.60%) |
10/20/2017 3:56pm |
|
Open: |
3.89 |
Pre close: |
3.84 |
Target:
|
5.35 
|
|
High: |
4.14 |
Low: |
3.83 |
Resistance:
|
4.58
5.18
|
|
Volume: |
43,500 |
Market Cap: |
69.90M |
Support:
|
3.60
3.00
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.89
|
MACD |
MACD(12,26):
|
-0.34  |
|
MA(20): |
4.45 |
Signal(12,26,9): |
-0.29 |
|
MA(100): |
5.59 |
Stochastic Oscillator |
%K(14,3):
|
15.70 |
|
MA(250): |
8.46 |
%D(3): |
10.45 |
|
Average Volume(K) |
3-Month: |
3484
|
52-Week |
High:
|
13.90 |
|
10-Days: |
1963 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
34.45 |
Change(%): |
-56.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.750 |
Return on Equity (ttm) |
-0.2 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
0.9 |
Shares Float (M) |
7.30 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
0.94 |
% Held by Insiders |
70.21 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
16.8 |
% Held by Institutions |
16.79 |
|
Forward EPS |
0.320 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
212 |
|
Book Value (p.s.) |
3.140 |
EBITDA (p.s.) |
0.122 |
P/E |
-5.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.25 |
|
Profit Margin |
-0.42 |
Operating Cash Flow
(M) |
4.12 |
P/S |
21180486.00 |
|
Operating Margin |
3.04 |
Levered Free Cash Flow
(M) |
-1.15 |
P/CF |
0.00 |
|
|
|
|
|
|
|
